Stocktoria
ANAPTYSBIO, INC ANAB
ANAPTYSBIO, INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $234.6M | $91.3M | $17.2M | $10.3M | $63.2M | $75.0M | $8.0M | $5.0M | $10.0M | $16.7M |
| R&D expense | — | — | — | $88.8M | $98.5M | $80.0M | $99.3M | $56.2M | $29.4M | $15.4M |
| Operating income | $47.9M | -$114.9M | -$164.4M | -$115.2M | -$56.8M | -$23.9M | -$107.4M | -$66.7M | -$28.8M | -$3.0M |
| Interest expense | — | — | — | — | $0 | $0 | $1.0M | $1.7M | $1.8M | $458,000 |
| Income tax | $164,000 | $3,000 | -$4,000 | $24,000 | $0 | $0 | -$152,000 | -$192,000 | $0 | $0 |
| Net income | -$13.2M | -$145.2M | -$163.6M | -$128.7M | -$57.8M | -$19.9M | -$97.3M | -$61.7M | -$30.1M | -$4.3M |
| EPS (diluted) | $-0.46 | $-5.12 | $-6.08 | $-4.57 | $-2.11 | $-0.73 | $-3.60 | $-2.50 | $-1.52 | $-1.62 |
| Operating cash flow | $19.7M | -$135.3M | -$120.8M | -$73.6M | -$45.9M | -$14.2M | -$69.5M | -$48.5M | -$19.4M | -$9.0M |
| Free cash flow | $19.6M | -$135.7M | -$121.6M | -$74.0M | -$47.3M | -$14.7M | -$70.3M | -$49.6M | -$19.7M | -$9.1M |
| Cash & equivalents | $238.2M | $123.1M | $36.0M | $71.3M | $495.7M | $250.5M | $171.0M | $113.6M | $81.2M | $51.2M |
| Total assets | $364.4M | $483.8M | $452.4M | $610.4M | $643.1M | $416.6M | $435.2M | $509.0M | $329.4M | $62.2M |
| Shareholders' equity | $37.2M | $70.9M | $88.1M | $262.1M | $356.4M | $396.7M | $405.0M | $486.4M | $307.6M | -$38.2M |
Growth · year-over-year · Revenue CAGR 34.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +157.0% | +432.0% | +66.8% | -83.7% | -15.8% | +837.5% | +60.0% | -50.0% | -40.1% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.